Five-year results presented at ASTRO 2026 show a five-week radiation schedule after prostatectomy controls cancer as well as a seven-week course. But serious urinary side effects were more common.
American Society for Radiation Oncology | Strategic Alliance Partners
Latest from American Society for Radiation Oncology
A study of more than 17,000 patients ages 23 to 64, presented at ASTRO 2026, found that only about 28% took endocrine therapy consistently for five years, and people who skipped radiation were more likely to fall off. Here's what to weigh before making that choice.
Advertisement
Advertisement
Trending on CURE
1
Exercise Gave Me Control. It Didn’t Cure My Cancer
2
Living With Incurable Cancer: The Emotional Toll of Never Knowing What Comes Next
3
A Light-Based Treatment Is Now FDA Approved for a Common Skin Cancer
4
Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free
5